Charles and Kate's cancer struggles having profound impact on fellow sufferers
LONDON : King Charles and his daughter-in-law Kate's public battles with cancer have had a huge impact on fellow sufferers, encouraging them to be open about the difficulties of coping with the illness, a leading cancer support charity says.
The news that both the 76-year-old monarch and Kate, 43, wife of his elder son and heir Prince William, were both undergoing treatment for the disease in early 2024 shocked Britain, but their response has been praised by medical professionals and those who help people with the condition.
While both have returned to official duties, Charles is still receiving treatment and Kate's workload remains closely controlled despite her now being in remission.
Laura Lee, the chief executive of Maggie's which runs support centres based next to hospitals, said the two royals' open discussions of their own personal issues in coping with the illness had had a profound impact.
'For the king, talking as a man and talking about living with an ongoing treatment of cancer, that has helped men talk about cancer,' she told Reuters. 'We saw last year a 12% increase of men coming into Maggie's Centres directly as a result of the king being open about his cancer diagnosis.'
'I think what Princess Kate has brought to it is a different experience, now she's talking about having finished her treatment but still having to live with the ongoing impacts of that treatment.'
Earlier this month, shortly after she pulled out of an engagement, Kate said she had put on a 'brave face' during her cancer treatment, describing the experience as being like a 'rollercoaster'.
'I felt exactly the same as she did,' Tracey Bradshaw, 56, who is being monitored after being treated for bladder cancer in 2021, told Reuters at a Maggie's Centre in west London.
'It's … the aftermath when the appointments start to trail off … you don't see that lovely clinical nurse specialist that you absolutely adore or you haven't got that sort of regular trips to … whatever clinic you go to and I really identified with that.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
3 days ago
- The Star
China reports record wave of mosquito-borne chikungunya virus
Guangdong province has launched stricter anti-mosquito measures, including urging residents to clear stagnant water. -- PHOTO: UNSPLASH via The Straits Times/ANN BEIJING (Bloomberg): A city in China's southern industrial hub has recorded 3,195 chikungunya cases so far this month, the country's biggest outbreak of the mosquito-borne virus since it first emerged in the mainland nearly two decades ago. Foshan city - in Guangdong Province, just north of Hong Kong - first reported an imported chikungunya case earlier in July, China's national broadcaster CCTV said, citing briefings from local authorities. Infections have soared by more than 2,700 in the past week alone. While Chinese health officials have yet to explain what's behind the outbreak, Guangdong has launched stricter anti-mosquito measures, including urging residents to clear stagnant water and make sure drainage channels remain unobstructed. Chikungunya, first identified in 1952 in Tanzania, is transmitted to humans by infected mosquitoes, the World Health Organization says. The virus causes fever and severe joint pain, and other symptoms can include headaches, muscle pain, vomiting and fatigue. The outbreak in Guangdong, an often hot and humid area of southern China, is the latest sign that tropical diseases - from dengue to malaria and zika - are expanding their reach, as climate change lets mosquitoes live in new territories that have become warmer and wetter. Increased international travel and low population immunity are also helping the spread. An explosion in cases in the Indian Ocean since the start of 2025 has sparked concerns of a spread to other countries, leading the WHO to issue an urgent call to action this week, Reuters reported. France and Italy, thousands of miles from the region, have both found locally-acquired chikungunya cases this year. "The surge in chikungunya cases is likely due to favorable climatic conditions that allow blooms of the Aedes mosquito population,' said Robert Jones, Assistant Professor in the Department of Disease Control at the London School of Hygiene & Tropical Medicine. "These are aggressive, day-biting mosquitoes that thrive in warm, wet conditions.' More than five billion people live in areas across 119 countries at risk from chikungunya, the WHO told reporters in Geneva, Reuters said. Some 220,000 cases and 80 related deaths have been reported in 14 countries and territories globally so far this year, according to the European Centre for Disease Prevention and Control. China recorded its first chikungunya case in 2008, an imported infection detected at an airport in Guangdong. The first locally transmitted cases - infecting 253 people - were reported in the province two years later. Since then, only sporadic cases have been found, in Yunnan and Fujian provinces. Globally, population susceptibility is likely elevated in areas where chikungunya outbreaks haven't tended to occur, said Patricia Gallego Delgado, Associate Director at London-based disease forecasting firm Airfinity Ltd. The wave is "attributable to lower levels of population immunity as individuals in these regions may have had limited or no prior exposure to the virus,' she said. -- ©2025 Bloomberg L.P.
Malay Mail
4 days ago
- Malay Mail
Floating babies, cosmic radiation and zero-gravity birth: What space pregnancy might actually involve
LONDON, July 24 — As plans for missions to Mars accelerate, so do questions about how the human body might cope. A return trip to the red planet would give more than enough time for someone to become pregnant and even give birth. But could a pregnancy be conceived and carried safely in space? And what would happen to a baby born far from Earth? Most of us rarely consider the risks we survived before birth. For instance, about two thirds of human embryos do not live long enough to be born, with most losses happening in the first few weeks after fertilisation; often before a person even knows they're pregnant. These early, unnoticed losses usually happen when an embryo either fails to develop properly or to implant successfully in the wall of the womb. Pregnancy can be understood as a chain of biological milestones. Each one must happen in the right order and each has a certain chance of success. On Earth, these odds can be estimated using clinical research and biological models. My latest research explores how these same stages might be affected by the extreme conditions of interplanetary space. Microgravity, the near-weightlessness experienced during spaceflight, would make conception more physically awkward but probably wouldn't interfere much with staying pregnant once the embryo has implanted. However, giving birth, and looking after a newborn, would be far more difficult in zero gravity. After all, in space, nothing stays still. Fluids float. So do people. That makes delivering a baby and caring for one a much messier and more complicated process than on Earth, where gravity helps with everything from positioning to feeding. At the same time, the developing foetus already grows in something like microgravity. It floats in neutrally buoyant amniotic fluid inside the womb, cushioned and suspended. In fact, astronauts train for spacewalks in water tanks designed to mimic weightlessness. In that sense, the womb is already a microgravity simulator. But gravity is only part of the picture. Radiation Outside Earth's protective layers, there's a more dangerous threat: cosmic rays. These are high-energy particles — 'stripped-down' or 'bare' atomic nuclei — that race through space at nearly the speed of light. They're atoms that have lost all their electrons, leaving just the dense core of protons and neutrons. When these bare nuclei collide with the human body, they can cause serious cellular damage. Here on Earth, we're protected from most cosmic radiation by the planet's thick atmosphere and, depending on the time of day, tens of thousands to millions of miles of coverage from the Earth's magnetic field. In space, that shielding disappears. When a cosmic ray passes through the human body, it may strike an atom, strip its electrons, and smash into its nucleus, knocking out protons and neutrons and leaving behind a different element or isotope. This can cause extremely localised damage — meaning that individual cells, or parts of cells, are destroyed while the rest of the body might remain unaffected. Sometimes the ray passes right through without hitting anything. But if it hits DNA, it can cause mutations that increase the risk of cancer. Even when cells survive, radiation can trigger inflammatory responses. That means the immune system overreacts, releasing chemicals that can damage healthy tissue and disrupt organ function. In the first few weeks of pregnancy, embryonic cells are rapidly dividing, moving, and forming early tissues and structures. For development to continue, the embryo must stay viable throughout this delicate process. The first month after fertilisation is the most vulnerable time. A single hit from a high-energy cosmic ray at this stage could be lethal to the embryo. However, the embryo is very small — and cosmic rays, while dangerous, are relatively rare. So a direct hit is unlikely. If it did happen, it would probably result in an unnoticed miscarriage. Pregnancy risks As pregnancy progresses, the risks shift. Once the placental circulation — the blood flow system that connects mother and foetus — is fully formed by the end of the first trimester, the foetus and uterus grow rapidly. That growth presents a larger target. A cosmic ray is now more likely to hit the uterine muscle, which could trigger contractions and potentially cause premature labour. And although neonatal intensive care has improved dramatically, the earlier a baby is born, the higher the risk of complications, particularly in space. On Earth, pregnancy and childbirth already carry risks. In space, those risks are magnified — but not necessarily prohibitive. But development doesn't stop at birth. A baby born in space would continue growing in microgravity, which could interfere with postural reflexes and coordination. These are the instincts that help a baby learn to lift its head, sit up, crawl, and eventually walk: all movements that rely on gravity. Without that sense of 'up' and 'down,' these abilities might develop in very different ways. And the radiation risk doesn't go away. A baby's brain continues to grow after birth, and prolonged exposure to cosmic rays could cause permanent damage — potentially affecting cognition, memory, behaviour and long-term health. So, could a baby be born in space? In theory, yes. But until we can protect embryos from radiation, prevent premature birth, and ensure babies can grow safely in microgravity, space pregnancy remains a high-risk experiment – one we're not yet ready to try. — Reuters
Malay Mail
6 days ago
- Malay Mail
From painkillers to antibiotics: Five medicines that could harm your hearing
LONDON, July 22 — When we think about the side effects of medicines, we might think of nausea, fatigue or dizziness. But there's another, lesser-known risk that can have lasting — and sometimes permanent — consequences: hearing loss. A wide range of prescription and over-the-counter drugs are known to be ototoxic, meaning they can damage the inner ear and affect hearing or balance. Ototoxicity refers to drug or chemical-related damage to the cochlea, which affects hearing, and the vestibular system, which controls balance. Symptoms can include tinnitus (ringing in the ears), hearing loss (often starting with high-frequency sounds), dizziness or balance problems or a sensation of fullness in the ears. These effects can be temporary or permanent, depending on the drug involved, the dose and duration and a person's susceptibility. The inner ear is highly sensitive, and most experts believe ototoxic drugs cause damage by harming the tiny hair cells in the cochlea or disrupting the fluid balance in the inner ear. Once these hair cells are damaged, they don't regenerate — making hearing loss irreversible in many cases. Around 200 medicines are known to have ototoxic effects. Here are some of the most commonly used drugs to watch out for: 1. Antibiotics Aminoglycoside antibiotics like gentamicin, tobramycin and streptomycin are typically prescribed for serious infections such as sepsis, meningitis, or tuberculosis — conditions where prompt, aggressive treatment can be lifesaving. In these cases, the benefits often outweigh the potential risk of hearing loss. These drugs, usually given intravenously, are among the most well-documented ototoxic medications. They can cause irreversible hearing loss, particularly when used in high doses or over extended periods. Some people may also be genetically more vulnerable to these effects. These drugs linger in the inner ear for weeks or even months, meaning damage can continue after treatment has ended. Other antibiotics to be aware of include macrolides (such as erythromycin and azithromycin) and vancomycin, which have also been linked to hearing problems, particularly in older adults or people with kidney issues. 2. Heart medicines Loop diuretics like furosemide and bumetanide are commonly used to manage heart failure or high blood pressure. When given in high doses or intravenously, they can cause temporary hearing loss by disrupting the fluid and electrolyte balance in the inner ear. Around 3 per cent of users may experience ototoxicity. Some blood pressure medications have also been linked to tinnitus. These include ACE inhibitors — drugs like ramipril that help relax blood vessels by blocking a hormone called angiotensin, making it easier for the heart to pump blood — and calcium-channel blockers like amlodipine, which reduce blood pressure by preventing calcium from entering the cells of the heart and blood vessel walls. While these associations have been observed, more research is needed to fully understand the extent of their effect on hearing. 3. Chemotherapy Certain chemotherapy drugs, especially those containing platinum — like cisplatin and carboplatin — are known to be highly ototoxic. Cisplatin, often used to treat testicular, ovarian, breast, head and neck cancers, carries a significant risk of permanent hearing loss. That risk increases when radiation is also directed near the head or neck. Up to 60 per cent of patients treated with cisplatin experience some degree of hearing loss. Researchers are exploring ways to reduce risk by adjusting dosage or frequency without compromising the drug's effectiveness. 4. Painkillers High doses of common pain relievers, including aspirin, NSAIDs — non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen, commonly used to relieve pain, inflammation and fever — and even paracetamol, have been linked to tinnitus and hearing loss. A large study found that women under 60 who regularly took moderate-dose aspirin (325 mg or more, six to seven times per week) had a 16 per cent higher risk of developing tinnitus. This link was not seen with low-dose aspirin (100 mg or less). Frequent use of NSAIDs as well as paracetamol was also associated with a nearly 20 per cent increased risk of tinnitus, particularly in women who used these medications often. Another study linked long-term use of these painkillers to a higher risk of hearing loss, especially in men under 60. In most cases, tinnitus and hearing changes resolve once the medication is stopped — but these side effects typically occur after prolonged, high-dose use. 5. Antimalarial drugs Drugs like chloroquine and quinine — used to treat malaria and leg cramps — can cause reversible hearing loss and tinnitus. One study found that 25-33 per cent of people with hearing loss had previously taken one of these drugs. Hydroxychloroquine, used to treat lupus and rheumatoid arthritis, has a similar chemical structure and poses a similar risk. While some people recover after stopping the drug, others may experience permanent damage, particularly after long-term or high-dose use. People with pre-existing hearing loss, kidney disease, or genetic susceptibility face higher risks — as do those taking multiple ototoxic drugs at once. Children and older adults may also be more vulnerable. If you're prescribed one of these medications for a serious condition like cancer, sepsis or tuberculosis, the benefits usually outweigh the risks. But it's still wise to be informed. Ask your doctor or pharmacist if your medicine carries a risk to hearing or balance. If you experience ringing in your ears, dizziness, or muffled hearing, report it promptly. — Reuters
